ライフサイエンスコーパス: ASCUS

1 sts were $5825 to $33781 for each additional ASCUS or AGUS diagnosis.

2 specimens from women referred because of an ASCUS Pap test.

3 amous intraepithelial lesions) because of an ASCUS Papanicolaou smear were tested by all three assays

4 Prevalence of genital hrHPV, HPV16, and ASCUS or worse cytology was 30%, 4%, and 28%.

5 Prevalence of anal hrHPV, HPV16, and ASCUS or worse cytology was 61%, 13%, and 68%.

6 infection, 6-month persistent infection, and ASCUS+, respectively.

7 ) against the detection of HSILs, LSILs, and ASCUS, respectively.

8 The multi-center ASCUS-LSIL Triage Study has shown that HPV DNA testing c

9 their prevalence in abnormal cytology (from ASCUS to cervical cancer) among Mexican women which were

10 in screening populations are identified from ASCUS Pap test results.

11 lls of undetermined significance or greater (ASCUS+), and cervical intraepithelial neoplasia grades 1

12 d rescreening identified a few more cases of ASCUS than did manual rescreening, but at a relatively h

13 mear samples with a cytological diagnosis of ASCUS and 39 samples with a negative diagnosis were test

14 r high-risk HPV types, or had Pap results of ASCUS or higher, were considered to have positive screen

15 inations, 995 women with Pap test results of ASCUS who consented to participate were identified.

16 positivity was associated with lower risk of ASCUS+ and CIN1+, no association between naturally acqui

17 ristics of the Inv2 test in the screening of ASCUS cervical cytology specimens and correlates the res

18 ) of thin-layer Pap (with a result of > or = ASCUS) for identifying women with CIN 3 or higher was on

19 for thin-layer Pap (with a result of > or = ASCUS), 78.8% (77.9%-79.7%) for PCR, and 72.6% (69.4%-75

20 amous cells of underdetermined significance (ASCUS) detected by Pap test to determine the need for co

21 squamous cells of undetermined significance (ASCUS) and 1 as atypical glandular cells of undetermined

22 squamous cell of undetermined significance (ASCUS) and CIN1, with a sensitivity and specificity exce

23 squamous cells of undetermined significance (ASCUS) and low-grade squamous intraepithelial lesion (LS

24 Squamous Cell of Undetermined Significance (ASCUS) and Low-Grade Squamous Intraepithelial Lesion Tri

25 squamous cells of undetermined significance (ASCUS) has clinical usefulness.

26 squamous cells of undetermined significance (ASCUS) or worse underwent high-resolution anoscopy and b

27 squamous cells of undetermined significance (ASCUS) presents a clinical challenge.

28 squamous cells of undetermined significance (ASCUS) presents a significant clinical issue, often depe

29 squamous cells of undetermined significance (ASCUS), low-grade squamous intraepithelial lesions (LSIL

30 squamous cells of undetermined significance (ASCUS); 2173 with low-grade and 1282 with high-grade squ

31 squamous cells of undetermined significance [ASCUS] or low-grade squamous intraepithelial lesions) be

32 using a nested case-control design from the ASCUS-LSIL Triage Study, we selected women with incident

33 ively, at the time of enrollment into in the ASCUS-LSIL (Atypical Squamous Cells of Undetermined Sign

34 tudy subjects were 821 women enrolled in the ASCUS-LSIL Triage Study who tested positive for HPV-16 a

35 s of specimens from 86 women enrolled in the ASCUS-LSIL Triage Study.

36 dings, but this proportion increased through ASCUS, low-grade squamous intraepithelial lesions, CIN1,

37 Of 995 participants with ASCUS Pap test results, 973 had both a definitive histol

38 al concern in the follow-up of patients with ASCUS.

39 , signal amplification testing of women with ASCUS and referral of those with a positive result was a

40 Only 5% to 10% of women with ASCUS harbor serious cervical disease, but more than one

41 th referral for colposcopy of all women with ASCUS or higher, signal amplification testing of women w

42 For women with ASCUS Pap tests, HPV DNA testing of residual specimens c

43 ogical aHSIL was detected in 42% of WWH with ASCUS or worse anal cytology.